732 related articles for article (PubMed ID: 21563292)
21. Long-term follow up of secundum atrial septal defect closure with the amplatzer septal occluder.
Knepp MD; Rocchini AP; Lloyd TR; Aiyagari RM
Congenit Heart Dis; 2010; 5(1):32-7. PubMed ID: 20136855
[TBL] [Abstract][Full Text] [Related]
22. Transcatheter closure of secundum atrial septal defects with the Amplatzer septal occluder in adults and children-follow-up closure rates, degree of mitral regurgitation and evolution of arrhythmias.
Wilson NJ; Smith J; Prommete B; O'Donnell C; Gentles TL; Ruygrok PN
Heart Lung Circ; 2008 Aug; 17(4):318-24. PubMed ID: 18407789
[TBL] [Abstract][Full Text] [Related]
23. Risk of cerebral embolism after interventional closure of symptomatic patent foramen ovale or atrial septal defect: a diffusion-weighted MRI and neuron-specific enolase-based study.
Oktay Tureli H; Ungan I; Tureli D; Demir B; Pirhan O; Bayrak HI; Caglar IM; Karakaya O; Inci E
J Invasive Cardiol; 2013 Oct; 25(10):519-24. PubMed ID: 24088426
[TBL] [Abstract][Full Text] [Related]
24. Outcome after percutaneous closure of a patent foramen ovale using the Intrasept device: a multi-centre study.
Luermans JG; Post MC; Schräder R; Sluysmans T; Vydt T; Vermeersch P; Chessa M; Onorato E; Goy JJ; Budts WI
Catheter Cardiovasc Interv; 2008 May; 71(6):822-8. PubMed ID: 18324695
[TBL] [Abstract][Full Text] [Related]
25. Intracardiac echocardiography during atrial septal defect and patent foramen ovale device closure in pediatric and adolescent patients.
Medford BA; Taggart NW; Cabalka AK; Cetta F; Reeder GS; Hagler DJ; Johnson JN
J Am Soc Echocardiogr; 2014 Sep; 27(9):984-90. PubMed ID: 24998516
[TBL] [Abstract][Full Text] [Related]
26. Initial experience with a transcatheter septal closure system for secondary stroke prevention in patients with interatrial septal defects.
Silverman IE; Kiernan FJ; Kelsey AM; Brakoniecki JJ; Kazi FA; Dougherty JE; Boden WE; McKay RG
Conn Med; 2003 Mar; 67(3):135-44. PubMed ID: 12687787
[TBL] [Abstract][Full Text] [Related]
27. Percutaneous transcatheter closure of interatrial septal defect in adults: procedural outcome and long-term results.
Kefer J; Sluysmans T; Hermans C; El Khoury R; Lambert C; Van de Wyngaert F; Ovaert C; Pasquet A
Catheter Cardiovasc Interv; 2012 Feb; 79(2):322-30. PubMed ID: 21523898
[TBL] [Abstract][Full Text] [Related]
28. Analysis of maximum P-wave duration and dispersion after percutaneous closure of atrial septal defects: comparison of two septal occluders.
Paç FA; Balli S; Topaloğlu S; Ece I; Oflaz MB
Anadolu Kardiyol Derg; 2012 May; 12(3):249-54. PubMed ID: 22381925
[TBL] [Abstract][Full Text] [Related]
29. Cardiac dysrhythmias after transcatheter closure of ASD with Amplatzer device.
Celiker A; Ozkutlu S; Karakurt C; Karagöz T
Turk J Pediatr; 2005; 47(4):323-6. PubMed ID: 16363340
[TBL] [Abstract][Full Text] [Related]
30. Percutaneous closure of atrial septal defects: a decade of experience at a reference center.
Fiarresga A; De Sousa L; Martins JD; Ramos R; Paramés F; Freitas I; Oliveira JA; Trigo C; Agapito A; Ferreira RC; Pinto F
Rev Port Cardiol; 2010 May; 29(5):767-80. PubMed ID: 20866006
[TBL] [Abstract][Full Text] [Related]
31. Percutaneous closure of patent foramen ovale and atrial septal defect in adults: the impact of clinical variables and hospital procedure volume on in-hospital adverse events.
Opotowsky AR; Landzberg MJ; Kimmel SE; Webb GD
Am Heart J; 2009 May; 157(5):867-74. PubMed ID: 19376313
[TBL] [Abstract][Full Text] [Related]
32. Long-term (5- to 20-year) outcomes after transcatheter or surgical treatment of hemodynamically significant isolated secundum atrial septal defect.
Kutty S; Hazeem AA; Brown K; Danford CJ; Worley SE; Delaney JW; Danford DA; Latson LA
Am J Cardiol; 2012 May; 109(9):1348-52. PubMed ID: 22335856
[TBL] [Abstract][Full Text] [Related]
33. [Chronic outcome of percutaneous transcatheter patent foramen ovale closure with Left-disk-coated patent foramen ovale occluder].
Huang YG; Zhang CJ; Huang XS; Huang T; Huang WH
Zhonghua Xin Xue Guan Bing Za Zhi; 2009 Dec; 37(12):1132-5. PubMed ID: 20193187
[TBL] [Abstract][Full Text] [Related]
34. Malattached septum primum and deficient septal rim predict unsuccessful transcatheter closure of atrial communications.
Ostermayer SH; Srivastava S; Doucette JT; Ko HH; Geiger M; Parness IA; Love BA
Catheter Cardiovasc Interv; 2015 Dec; 86(7):1195-203. PubMed ID: 26332722
[TBL] [Abstract][Full Text] [Related]
35. Closure of persistent foramen ovale with the BioSTAR biodegradable PFO closure device: feasibility and long-term outcome.
Karagianni A; Abrahamsson P; Furenäs E; Eriksson P; Dellborg M
Scand Cardiovasc J; 2011 Oct; 45(5):267-72. PubMed ID: 21728789
[TBL] [Abstract][Full Text] [Related]
36. Taming the "cobra": an approach to "cobra-like" formation seen in the Occlutech atrial septal defect and patent foramen ovale occluders.
Aaron S; Mainzer G; Lorber A
Catheter Cardiovasc Interv; 2012 Mar; 79(4):678-80. PubMed ID: 21805618
[TBL] [Abstract][Full Text] [Related]
37. Impact of Percutaneous Closure of Interatrial Shunts on Migraine Attacks: Single-Operator Series and Review of the Literature.
Manolis AS
Rev Recent Clin Trials; 2017; 12(2):129-138. PubMed ID: 28356032
[TBL] [Abstract][Full Text] [Related]
38. Intermediate and long-term outcome of patients after device closure of ASD with special reference to complications.
Kazmi T; Sadiq M; Asif-ur-Rehman ; Hyder N; Latif F
J Ayub Med Coll Abbottabad; 2009; 21(3):117-21. PubMed ID: 20929028
[TBL] [Abstract][Full Text] [Related]
39. Double standards in the world of ASD and PFO management: closure for paradoxical embolism.
Carroll JD
Catheter Cardiovasc Interv; 2009 Dec; 74(7):1070-1. PubMed ID: 19950331
[No Abstract] [Full Text] [Related]
40. Cardiac magnetic resonance imaging of atrial septal defect for transcatheter closure.
Durongpisitkul K; Tang NL; Soongswang J; Laohaprasitiporn D; Nana A; Kangkagate C
J Med Assoc Thai; 2002 Aug; 85 Suppl 2():S658-66. PubMed ID: 12403244
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
